Gsk (GSK) Property, Plant & Equipment (Net) (QoQ) (2009 - 2026)

Gsk (GSK) Property, Plant & Equipment (Net) (QoQ) (2009 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Gsk 96,436,181.12 Bn 96,436,176.16 Bn 7.76 Bn
2 Eli Lilly 1,017.30 Bn 1,012.01 Bn 16.22 Bn
3 Johnson & Johnson 579.61 Bn 557.55 Bn 15.96 Bn
4 AbbVie 402.30 Bn 392.96 Bn 10.78 Bn
5 Merck 294.24 Bn 288.59 Bn 12.09 Bn
6 Amgen 191.82 Bn 179.78 Bn 5.87 Bn
7 Gilead Sciences 155.93 Bn 148.21 Bn 5.52 Bn
8 Pfizer 149.05 Bn 136.28 Bn -1.21 Bn
9 Bristol Myers Squibb 116.33 Bn 105.88 Bn 8.07 Bn
10 Novartis Ag 112.59 Bn 111.90 Bn -

Historic Data

Download Data
DateValue
Mar 31, 2026 1.55%
Dec 31, 2025 -1.63%
Sep 30, 2025 3.63%
Jun 30, 2025 5.50%
Mar 31, 2025 -2.65%
Dec 31, 2024 2.59%
Sep 30, 2024 1.83%
Jun 30, 2024 -0.16%
Mar 31, 2024 1.43%
Dec 31, 2023 0.27%
Sep 30, 2023 3.01%
Jun 30, 2023 1.81%
Mar 31, 2023 1.60%
Dec 31, 2022 -0.12%
Sep 30, 2022 -2.03%
Jun 30, 2022 402.84%
Mar 31, 2022 -84.09%
Dec 31, 2021 -2.24%
Sep 30, 2021 -0.34%
Jun 30, 2021 1.25%